Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
Robison, Nathan J., Yeo, Kee Kiat, Berliner, Adrian P., Malvar, Jemily, Sheard, Michael A., Margol, Ashley S., Seeger, Robert C., Rushing, Teresa, Finlay, Jonathan L., Sposto, Richard, Dhall, GirishLanguage:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-018-2791-y
Date:
February, 2018
File:
PDF, 1.16 MB
english, 2018